Current Report Filing (8-k)
20 Dezember 2022 - 10:03PM
Edgar (US Regulatory)
0001715819
false
0001715819
2022-12-12
2022-12-12
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
SECURITIES AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event
reported): December 12, 2022
ELECTROMEDICAL TECHNOLOGIES, INC.
(Exact Name of Registrant as Specified
in its Charter)
| Delaware |
Commission File Number |
82-2619815 |
(State or other jurisdiction of
incorporation or organization) |
000-56192 |
(I.R.S. Employer
Identification Number) |
16561 N. 92nd Street, Ste. 101
Scottsdale, AZ 85260
(Address of Principal Executive Offices
and Zip Code)
888-880-7888
(Issuer's telephone number)
(Former Name or Former Address, if Changed
Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| | |
| ¨ | Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| | |
| ¨ | Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| | |
| ¨ | Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title
of Each Class |
Trading
Symbols |
Name
of Exchange on Which Registered |
| COMMON |
EMED |
NONE |
Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange
Act of 1934 (17 CFR §240.12b-2).
Emerging growth company x
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act.
Section 5 - Corporate Governance and Management
Item 5.02 Departure of Directors or Certain Officers; Election of
Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
On December 12, 2022,
Lee Benson resigned as an independent director of the Company. There was a disagreement with the Company on its compensation policy disclosable
under Item 5.02(a). The company provided Mr. Benson with a copy of the disclosures made in this Form 8-K before filing and informed Mr.
Benson of the opportunity to furnish a letter addressed to the company as promptly as possible stating whether he agrees with the company’s
disclosures in response to this item and, if not, stating the disagreements. The company will file any letter it receives from Mr. Benson
as an exhibit by amendment to the previously filed Form 8-K within two business days after receipt by the company.
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Dated December 20, 2022 | |
| | | |
| ELECTROMEDICAL TECHNOLOGIES, INC. | |
| | | |
| By: | /s/ Matthew Wolfson | |
| Matthew Wolfson | |
| Chief Executive Officer | |
| (Principal Executive Officer) | |
ElectroMedical Technolog... (PK) (USOTC:EMED)
Historical Stock Chart
Von Dez 2024 bis Jan 2025
ElectroMedical Technolog... (PK) (USOTC:EMED)
Historical Stock Chart
Von Jan 2024 bis Jan 2025
